This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock

Friday, January 20, 2023

Submitted by


Neel Vora, Rajvi Chaudhary, Hetarth Vivek Upadhyay, Ashwati Konat, Parit Zalavadia, Arif Padaniya, Parth Patel, Nihar Patel, Priyadarshi Prajjwal, Kamal Sharma

Researchers conducted a literature analysis to weigh the benefits and risks of using Impella versus ECMO for use in cases of cardiogenic shock. They reviewed each method’s efficacy, clinical outcomes, cost-effectiveness, complications, and limitations. The study found that Impella ranked higher in each of these categories but had inconclusive data on long-term results.

Add comment

Log in or register to post comments